Budesonide for Prevention of Acute Gastrointestinal GVHD Following Allogenic Stem Cell Transplantation
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether orale budesonide is effective in the
prevention of acute gastrointestinal graft-versus-host disease (GVHD) following allogenic
stem cell transplantation.